Podcasts about lobectomy

In this month's episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Thomas D'Amico about VATS lobectomy. Chapters 00:00 Introduction 01:47 Background 04:11 Indications 04:51 Preoperative Assessment 07:12 Setup 08:21 Patient Positioning 11:26 Basics 13:36 D'Amico's Port Placement 16:46 Uniportal 22:03 Steps 22:44 Anterior-Posterior Order 25:45 Anatomy 26:45 Instruments 30:54 Pleural Dissection 31:33 Inferior Pulmonary Ligament 31:39 Pulmonary Vein 32:01 Artery/Bronchus Dissection 33:38 Nodal Resection 36:25 Tips & Tricks 38:48 Specimen Removal 39:10 Closure 40:02 Postoperative Care 45:01 Outcomes 45:31 CT Surgery Training Advice They discuss the set-up, patient positioning, port placement, dissection of hilar structures, tips and tricks, and more. They also discuss preoperative assessment, nodal resection, specimen removal, closure, and outcomes.   The Atrium is a monthly podcast presenting clinical and career-focused topics for residents and early career professionals across all cardiothoracic surgery subspecialties. Watch for next month's episode on ECMO.   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning examines future cardiothoracic surgery robotic systems. Chapters 00:00 Intro 01:05 SCTS 2025 02:50 Intuitive Single-Port System 10:00 Other Robotics in Development 12:49 Medtronic Innovations 15:53 Tumor Air Spaces Spread 18:21 Virtual Reality Effect on Patients 19:58 MR for Isolated Leaflet Lesion 21:48 Post-Surgery Proning Obese ARS Syndrome 23:31 Robotic Bi Ortho Lung Transplant 25:51 Video Competition 2nd and 3rd Place 26:59 Repair of Bileaflet MV Prolapse 27:46 Robotic ASD Closure via LA 28:46 Upcoming Events 29:42 Women in Thoracic Surgery Webinar 30:46 Closing He discusses the new da Vinci Single-Port surgical system, single-port robotic systems, and the cost difference between single-port and multiport robotic systems. He also examines DV5 technology, the potential of utilizing lasers in robotics, and other practices that are interested in robotic systems.    Joel also reviews recent JANS articles addressing whether tumors spread through air spaces is a determinant for treatment of clinical stage I non-small cell lung cancer, the effect of virtual reality on postoperative anxiety and pain in patients following cardiac surgery, long-term results of edge-to-edge and neochordal mitral repair for isolated anterior leaflet lesions, the prone position in obese patients with acute respiratory distress syndrome after cardiothoracic surgery.   In addition, Joel explores minimally invasive bilateral orthotopic lung transplant with robotic assistance, repair of bileaflet mitral valve prolapse through an upper ministernotomy, and robotic-assisted atrial septal defect closure via the left atrium. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Tumour Spread Through Air Spaces Is a Determiner for Treatment of Clinical Stage I Non-Small Cell Lung Cancer: Thoracoscopic Segmentectomy vs Lobectomy  2.) The Effect of Virtual Reality on Postoperative Anxiety and Pain in Patients Following Cardiac Surgery: A Randomized Controlled Trial  3.) Long-Term Results of Edge-to-Edge and Neochordal Mitral Repair for Isolated Anterior Leaflet Lesion: A Propensity Match Analysis   4.) Prone Position in Obese Patients With Acute Respiratory Distress Syndrome After Cardio-Thoracic Surgery  CTSNET Content Mentioned  1.) Minimally Invasive Bilateral Orthotopic Lung Transplant With Robotic Assistance  2.) Repair of Bileaflet Mitral Valve Prolapse Through an Upper Ministernotomy  3.) Robotic-Assisted Atrial Septal Defect Closure Via the Left Atrium: Dual Case Reports  Other Items Mentioned  1.) Webinar Series: Women in Cardiothoracic Surgery—Advancement Through Collaboration  2.) 2024 CTSNet Resident Video Competition Winners  3.) President's Series With Husam Balkhy | ISMICS President  4.) Career Center   5.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. Diane's Story: I had no idea I was sick, never mind having lung cancer. There were times when I did feel something was not right with my health, but the doctors thought it was all in my head. So, I just continued living life. On December 9th , 2012, I started to get pains in my chest and felt sick to my stomach. My family thought I was having a heart attack and called 911. I was taken to the emergency room, and it was there after all the tests showing I wasn't having a heart attack; the doctor informed me that I had a mass in my chest. I cannot find the words to describe how I felt after the ER doctor so nonchalantly gave me the results of the chest x-ray. He then proceeded to give me morphine for the pain and medicine for the nausea. So that was the start of my surreal relationship with lung cancer. After having a PET scan and a CT Guided Biopsy, I was diagnosed with Primary, Thorax Small Cell Lung Cancer Stage, IIIA (T3, N2, M0, G2) Lymph-Vascular Invasion in my upper left lung and given the news on January 15, 2013. On January 31, 2013, I had surgery (Lobectomy) to remove the tumor from my upper left lung. Now the treatments begin to lessen the possibility of cancer recurring in my lungs and keep it from spreading to other parts of my body. My first round of chemotherapy in March 2013 almost killed me. The day after my first treatment I had to be admitted into the hospital because, I was allergic to the chemo drug, cisplatin. I was unable to eat for a week. I was so sick, and my potassium and magnesium level were extremely low. I thought I was going to die. After this incident, I was told there was nothing else they could do for me, so I opted for a second opinion.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning discusses the robotic market. He explores the new FDA approval for the Johnson & Johnson robotic surgical system for clinical trials, the background of Johnson & Johnson MedTech, and the location for this trial. He also discusses the details of TAVR, what we currently know about TAVR, and highlights an article by Steve Bell that discusses his own views on Johnson & Johnson and the robotic market.    Joel also reviews recent JANS articles on The Society of Thoracic Surgeons expert consensus on the multidisciplinary management and resectability of locally advanced non-small cell lung cancer, a European multicenter study evaluating the prognosis of peripheral early-stage lung adenocarcinoma patients operated on by segmentectomy or lobectomy, early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis, and the use of hybrid stage I to stratify between single ventricle palliation and biventricular repair.   In addition, Joel explores an off-pump ASD closure with a two-layer patch attached to the right atrium, a repair of Scimitar syndrome in a two-year-old via VRAT, and robotic-assisted carinal reconstruction using cross table ventilation. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung Cancer  2.) European Multicentre Study Evaluating the Prognosis of Peripheral Early-Stage Lung Adenocarcinoma Patients Operated on by Segmentectomy or Lobectomy  3.) Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED trial  4.) Use of Hybrid Stage I to Stratify Between Single Ventricle Palliation and Biventricular Repair  CTSNET Content Mentioned  1.) Off-Pump ASD Closure With a Two-Layer Patch Attached to the Right Atrium  2.) Repair of Scimitar Syndrome in a Two-Year-Old Via VRAT: Pitfalls of Intra-atrial Baffle  3.) Robotic-Assisted Carinal Reconstruction Using Cross Table Ventilation—A Novel Surgical Technique  Other Items Mentioned  Why am I so tough on Johnson & Johnson and Medtronic and their surgical robotic programs?  CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning had the opportunity to speak with Dr. Donald Nuss about the NUSS procedure at the 24th Annual Congress: Chest Wall International Group and Phoenix Advanced Pectus Course 2024. They discussed how this procedure was created, how it has evolved, and bar stabilization. They also discuss treatments for pectus excavatum and the Ravitch procedure.  Joel also reviews recent JANS articles on real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage C-IA lung carcinoma, branched stented anastomosis frozen elephant trunk repair, selection for transcatheter versus surgical aortic valve replacement and mid-term survival, and treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer receiving neoadjuvant immunochemotherapy. In addition, Joel explores the Chrysalis technique, updates on Y-incision aortic annular enlargement, and redo mitral valve repair and left ventricular myectomy. Before closing, he shares upcoming events in CT surgery.  JANS Items Mentioned 1.) Real-World Outcomes of Lobectomy, Segmentectomy and Wedge Resection for the Treatment of Stage C-IA Lung Carcinoma 2.) Branched Stented Anastomosis Frozen Elephant Trunk Repair: Early Results From a Physician-Sponsored Investigational Device Exemption Study 3.) Selection for Transcatheter Versus Surgical Aortic Valve Replacement and Mid-Term Survival: Results of the AUTHEARTVISIT Study 4.) Treatment Patterns and Clinical Outcomes of Patients With Resectable Non–Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy: A Large-Scale, Multicenter, Real-World Study (NeoR-World) CTSNET Content Mentioned 1.) The Chrysalis Technique: A Unique New Way to Perform an Aortic Root Replacement 2.) Updates on Y-Incision Aortic Annular Enlargement 3.) Redo Mitral Valve Repair and Left Ventricular Myectomy Other Items Mentioned CTSNet Events Calendar Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This week on The Beat, Editor in Chief Joel Dunning speaks with Brian Houseman about VATS vs robotic lobectomy. They discuss training programs, the speed and efficiency of VATS, advanced chemotherapy cases, instruments used, safety, and the difference in pain for robotic-assisted surgery vs VATS.   Joel also discusses EACTS/STS guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ, percutaneous versus surgical femoral cannulation in minimally invasive cardiac surgery, 2024 ESC guidelines for the management of chronic coronary syndromes, and transcatheter myotomy to reduce left ventricular outflow obstruction SESAME technique.   In addition, Joel highlights a robotic-assisted left lower lobectomy for NSCLC after neoadjuvant chemoimmunotherapy, chordal repair of P2 and P3 and left atrial appendage stapling through an upper mini sternotomy, and the Bookwalter retractor. Before closing, he shares upcoming events in CT surgery.  JANS Items Mentioned  1.) EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ  2.) Percutaneous Versus Surgical Femoral Cannulation in Minimally Invasive Cardiac Surgery: A Systematic Review and Meta-Analysis  3.) 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes  4.) Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction   CTSNET Content Mentioned  1.) Robotic-Assisted Left Lower Lobectomy for NSCLC After Neoadjuvant Chemoimmunotherapy  2.) Chordal Repair of P2 and P3 and Left Atrial Appendage Stapling Through an Upper Mini Sternotomy  3.) The Bookwalter Retractor—A Resident's Best Friend  Other Items Mentioned  CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This week on The Beat, Editor in Chief Joel Dunning speaks with Dr. Raja Flores about VATS lobectomy. They discuss his experience and studies in VATS lobectomy and Dr. Flores's technique for this procedure.   He also discusses the evolution of the treatment of non-small cell lung cancer, percutaneous coronary intervention versus coronary artery bypass grafting for left main disease, current indications and surgical strategies for myocardial revascularization in patients with left ventricular dysfunction, and pneumonectomy following penetrating trauma with ECMO as postoperative support.  In addition, Joel discusses a bilateral internal mammary artery harvest using an SSi MANTRA, sinus venosus atrial septal defect repair using a beating heart technique, and another installment in Dr. Tristan Yan's aortic repair series focused on mega-thoracic aortic aneurysm repair. Before closing, Joel discusses upcoming events in CT surgery.  JANS Items Mentioned  1.) The Evolution of the Treatment of Non-Small Cell Lung Cancer: A Shift in Surgical Paradigm to a More Individualized Approach  2.) Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease According to Age  3.) Current Indications and Surgical Strategies for Myocardial Revascularization in Patients With Left Ventricular Dysfunction  4.) Pneumonectomy Following Penetrating Trauma With ECMO as Postoperative Support: Case Report—(Lung Trauma and ECMO)  CTSNET Content Mentioned  Bilateral Internal Mammary Artery Harvest Using an SSi MANTRA  Sinus Venosus Atrial Septal Defect Repair Using a Beating Heart Technique  Deep Dive Into Aortic Surgery: Mega-Thoracic Aortic Aneurysm Repair  Other Items Mentioned  CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this episode our team reviews the two groundbreaking RCTs which challenged the long-held dogma that a lobectomy is the only acceptable oncologic procedure for NSCLC. Listen as we compare and contrast the North American CALGB trial and Japanese JCOG trial which were both designed to investigate survival and recurrence outcomes by randomizing stage 1A patients to lobectomy versus a sublobar resection. Learning Objectives: -Compare and contrast the patient characteristics of the CALGB and JCOG trials -Understand the methodology each trial and be able to explain their nuanced differences -Analyze the results of the CALGB and JCOG trials and how they apply to patients today Hosts: Kelly Daus MD, Peter White MD, Eric Vallieres, MD and Brian Louie MD Referenced Material https://pubmed.ncbi.nlm.nih.gov/36780674/ Altorki N, et al. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023 Feb 9;388(6):489-498. doi: 10.1056/NEJMoa2212083. PMID: 36780674; PMCID: PMC10036605. https://pubmed.ncbi.nlm.nih.gov/35461558/' Saji H, et al. West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. PMID: 35461558. https://pubmed.ncbi.nlm.nih.gov/37473998/ Altorki N, et al. Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance). J Thorac Cardiovasc Surg. 2023 Jul 18:S0022-5223(23)00612-8. doi: 10.1016/j.jtcvs.2023.07.008. Epub ahead of print. PMID: 37473998. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our other Cardiothoracic episodes: https://behindtheknife.org/podcast-category/cardiothoracic/

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by Associate Editor Raymond L. Chai, MD, and lead author Julia E. Noel, MD, to discuss “Time-Driven Activity-Based Cost Comparison of Thyroid Lobectomy and Radiofrequency Ablation,” which published in the October 2023 issue of Otolaryngology–Head and Neck Surgery.  Dr. Noel and her coauthors used time-driven activity-based cost methodology to drill down the details that reveal radiofrequency ablation (RFA) is a more cost-effective treatment modality. They looked at the entire treatment cycle for both lobectomy and RFA— from initial visit in clinic through the procedure and postoperative visit—to determine cost data for the hospital.

In this episode of CTSNet's flagship podcast, editor in chief Joel Dunning runs through the latest, most popular content on ctsnet.org—the largest online community of CT surgeons and source of CT surgery information—and breaking cardiothoracic surgery news and research from around the world. Joel discusses minithoracotomy versus sternotomy for mitral valve repair, an AATS consensus on management of patients with early-stage non-small cell lung cancer, and wedge resection versus lobectomy for lung cancer with lymph node disease. He also talks about a case of Ravitch and mitral valve repair for a patient with Marfan syndrome, SVC cannula insertion and removal technique, and a CTSNet exclusive interview with Loretta Erhunmwunsee about her cross-cultural work in thoracic surgery. After discussing upcoming events in the CT surgery world, he closes with a shoutout to Tom Varghese and David Cooke for their podcast, Same Surgeon, Different Light. JANS Items Mentioned Minithoracotomy vs Conventional Sternotomy for Mitral Valve Repair: A Randomized Clinical Trial  The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and Multidisciplinary Management of Patients with Early-Stage Non-Small Cell Lung Cancer  Wedge Resection vs. Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer with Occult Lymph Node Disease  CTSNet Content Mentioned Concomitant Ravitch Repair and Mitral Valve Repair in a 13-Year-Old Patient with Marfan Syndrome Percutaneous Insertion and Removal Technique of Bio-Medicus Cannula as SVC Cannula for Cardiopulmonary Bypass Cultural Humility in Surgery: An Interview with Loretta Erhunmwunsee Other Items Mentioned Same Surgeon, Different Light CTSNet Events Calendar

John called and was soliciting the doctor's opinion regarding him getting a lobectomy. He was also was wondering where the church stood on this issue.

John called and was soliciting the doctor's opinion regarding him getting a lobectomy. He was also was wondering where the church stood on this issue.

Lung nodules are found in up to half of adults who get a chest x-ray or CT scan. Often called a spot on the lung or a shadow, they usually don't cause any noticeable problems. However, in some cases, they can be an early sign of cancer. That's why it's important to seek follow-up care to accurately diagnose and monitor lung nodules. During this podcast, Dr. Ziv Gamliel, chief of Thoracic Surgery at The Angelos Center for Lung Diseases at MedStar Franklin Square Medical Center discusses lung nodules…what they are and how they are diagnosed and treated. For interviews with Dr. Gamliel, or for more information about this podcast, contact Regional Media Relations Director, debra.schindler@medstar.net.Learn more about Dr. Gamliel here.   For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.12.22.521602v1?rss=1 Authors: Audrain, S., Barnett, A. J., McAndrews, M. P. Abstract: Objectives Anterior temporal lobectomy as a treatment for temporal lobe epilepsy is associated with a variable degree of postoperative memory decline, and estimating this decline for individual patients is a critical step of preoperative planning. Presently, predicting memory morbidity relies on indices of preoperative temporal lobe structural and functional integrity. However, epilepsy is increasingly understood as a network disorder, and memory a network phenomenon. We aimed to assess the utility of functional network measures to predict postoperative memory changes. Methods Patients with left and right temporal lobe epilepsy (TLE) were recruited from an epilepsy clinic. Patients underwent preoperative resting-state fMRI (rs-fMRI) and pre- and postoperative neuropsychological assessment approximately one year after surgery. We compared functional connectivity throughout the memory network of each patient to a healthy control template based on 19 individuals to identify differences in global organization. A second metric indicated the degree of integration of the to-be-resected temporal lobe with the rest of the memory network. We included these measures in a linear regression model alongside standard clinical and demographic variables as predictors of memory change after surgery. Results Seventy-two adults with TLE were included in this study (37 left/35 right). Left TLE patients with more abnormal memory networks, and with greater functional integration of the to-be-resected region with the rest of the memory network preoperatively, experienced the greatest decline in verbal memory after surgery. Together, these two measures explained 44% of variance in verbal memory change (F(2,31)=12.01, p=0.0001), outperforming standard clinical and demographic variables. None of the variables examined in this study were associated with visuospatial memory change in patients with right TLE. Conclusion Resting-state connectivity provides valuable information concerning both the integrity of to-be-resected tissue as well as functional reserve across memory-relevant regions outside of the to-be-resected tissue. Intrinsic functional connectivity has the potential to be useful for clinical decision-making regarding memory outcomes in left TLE, and more work is needed to identify the factors responsible for differences seen in right TLE. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

More than 200,000 people in the U.S. will be diagnosed with lung cancer in 2022, according to the National Cancer Institute. A new lung cancer diagnosis can be scary and confusing, but having a support system can help."Probably the best advice I give patients with lung cancer is to build your village of support around you," says Dr. Shanda Blackmon, a Mayo Clinic thoracic surgeon. "Always see if you can have somebody come with you for your appointment, just to help you emotionally deal with things, to help you record what's being said, to help you collect that information, and then to also advocate for you."If the cancer is confined to the lungs, surgery may be an option for treatment. Surgery is performed to remove the lung cancer and a margin of healthy tissue around the cancer site. Procedures to remove lung cancer include: Wedge resection to remove a small section of lung that contains the tumor along with a margin of healthy tissue. Segmental resection to remove a larger portion of lung, but not an entire lobe. Lobectomy to remove the entire lobe of one lung. Pneumonectomy to remove an entire lung. The surgeon also may remove lymph nodes from a patient's chest to check them for signs of cancer. The type of operation used for lung cancer treatment depends on the size and location of the cancer as well as how well a person's lungs are functioning. Dr. Blackmon recommends that patients explore all their surgical options."When you look at actual surgical options, you have minimally invasive surgery, or open surgery," explains Dr. Blackmon. "And the minimally invasive surgery has a lot of different options as well. Not every lung cancer surgery can be done minimally invasively. But if it can, certainly, the patient benefits."Another important consideration is having your lung cancer surgery performed at a center that does a high volume of cases and is familiar with the type of procedure needed."When you go to have your car worked on — you go to the dealership that deals with your car specifically and someone who does it every day — they're going to be doing a better job than going to someone who's never even seen that type, make or model of car," says Dr. Blackmon. "I think we do that in life all the time. And it makes sense to do it in medicine, and in surgery especially." After surgery for lung cancer, patients are often worried about short-term side effects, like shortness of breath and pain, as well as long-term worries about cancer recurrence. Both should be addressed as part of a cancer survivorship plan."Survivorship is part surveillance and part symptom management," says Dr. Blackmon. "The survivorship program here at Mayo Clinic really focuses on treating the whole patient. We have things like massage therapy. We have acupuncture. We have meditation. We have all kinds of resources that help patients to get their life back, get back in shape, and get all the parts of their body whole again as they start to heal from this really big surgery. But one thing that is so important is to continue to go back for that survivorship care with continued symptom monitoring and continued surveillance. That five-year period after the lung cancer surgery is so critically important."On this Mayo Clinic Q&A podcast, Dr. Blackmon discusses what people can expect after surgery for lung cancer, and how to achieve the best quality of life.

Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we sit down with Thoracic Surgeon, Dr. Jane Yanagawa to discuss surgical considerations in treatment of NSCLC. * How do you choose what type of surgical resection to do?- Considerations: --Lung anatomy --Location of the nodule within lung--Lymph node involvement-Options: --Pneumonectomy: removal of whole lung --Lobectomy: remove a whole lobe--Segmentectomy/sublobar resection: part of a lobe* What does “adequate margins” mean? And how do you know if it's enough?- If you're removing the whole lobe, it does not matter as much - If you're doing a segmentectomy, you want to have samples evaluated while in the OR because if there is signs of more disease that initially thought, you would take this one step further and do a lobectomy. - Need to consider the patient's situation - how good is their status * Why does preoperative workup matter?- Pulmonary function tests: Surgeons are looking at the %FEV1 and %DLCO to then predict what their function would be AFTER surgery. After surgery, they want to ensure patient has %FEV1 or %DLCO >40%. - Lung anatomy: In patients with COPD and endobronchial lesions, sometimes they also get V/Q scans to evaluate ratio- Cardiac echo: Important in pneumonectomy where removal of lung tissue will also remove a significant amount of blood vessels. Want to rule out pulmonary hypertension pre-operatively. - Pulmonary hypertension can also affect someone's survival while they're ventilating with only one lung during the procedure (“single lung ventilation”). - Smoking status: Smoking can increase complications by ~60%. - Pre-habilitation: Encouraging patients to be fit prior to surgery with walking, nutrition, +/- pulmonary rehabilitation* What is “VATS”?- VATS stands for video-assisted thoracoscopic surgery; it is not, in itself, a procedure. But a VATS allows for minimally invasive surgery through the use of a camera. - It involves three incisions (axilla, lowest part of mid-axillary line, one posterior)* In what scenario is a mediastinoscopy warranted? - Needed after EBUS if there is still high index of suspicion for cancer involvement in lymph nodes, even if lymph nodes are negative from EBUS* What is “systematic lymph node sampling”?- An organized way to sample lymph nodes, including all lymph nodes that are along the way, not just the ones that may be involved * As a surgeon, how do you determine if a patient is okay for surgery if the mass is invading another structure?- Need to take the anatomy into consideration - are there major blood vessels or nerves there, for instance, which can impact outcome and recovery.* When should we consider induction chemotherapy from a surgeon's perspective?- Lots of changes in this sphere coming; lots of discrepancy between institutions when there is N2 disease - In Dr. Yanagawa's opinion, anyone with N2 disease should get neoadjuvant therapy * If there is neoadjuvant chemoradiation given, how does that effect your surgery?- Radiation increases scar tissue in the lung tissue. But what is worse is that radiation neoadjuvantly may make wound healing more difficult. She does not prefer radiation pre-operatively- Chemotherapy also adds scar tissue*How does neoadjuvant IO therapy affect scar tissue formation?- The hilum and lymph nodes are more swollen, but does not translate to more complications - She has even seen patients who had gotten IO for another cancer and then get lung cancer, she can still appreciate swollen nodes!* How long after surgery is it safe to start adjuvant therapy?- If patient has a complication from surgery, would not start right away. It is important to discuss with the surgeon about when it is okay to proceed with adjuvant therapy. - If patient has good recovery/without complications, okay to start about 4 weeks after- There is no good guidance yet about when it is safe to start IO after surgery About our guest: Jane Yanagawa, MD is an Assistant Professor of Thoracic Surgery at the UCLA David Geffen School of Medicine and the UCLA Jonsson Comprehensive Cancer Center. She completed medical school at Baylor College of Medicine, after which she went to UCLA for her surgical residency. She went onto Memorial Sloan-Kettering for her Thoracic Surgery Fellowship. In addition to her practice as a thoracic surgeon at UCLA, Dr. Yanagawa also sits on the NCCN NSCLC guidelines committee! We are so grateful she was able to join us despite her very busy schedule! Please visit our website (TheFellowOnCall.com) for more information Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Lori Shipman is a survivor of Stage 1A lung cancer. Her journey began with a persistent cough, and after a lengthy chain of events came her diagnosis. But she survived and has returned to an active lifestyle, including swimming, kayaking and running.

Today we talk to Aswin Chari, an academic neurosurgical trainee; Ph.D. student at Great Ormond Street Hospital and UCL. When Aswin grows up, he wants to be an academic neurosurgeon (!); where he balances looking after patients and doing research into improving outcomes for children with epilepsy. Aswin is also the Clinical Fellow on the National Institute for Health and Care Excellence (NICE) guideline on the diagnosis and management of epilepsy, an Associate Editor for the British Journal of Neurosurgery, and the research lead for the neurosurgical charity Brainbook. **CONNECT WITH ASWIN**• Twitter: https://twitter.com/aswinchari **READ ABOUT ASWIN'S WORK**UCL: https://iris.ucl.ac.uk/iris/browse/profile?upi=ACHAB77ResearchGate: https://www.researchgate.net/profile/Aswin-ChariBrainbook: https://brainbookcharity.org/meet-the-team **CHECK OUT THE PODCAST WITH ASWIN**Available on Spotify, Apple, Google, Stitcher, Amazon Music, and Deezer - Type in “Epilepsy Sparks Insights”**CONNECT WITH TORIE**• Website: https://www.torierobinson.com• Twitter: https://twitter.com/torierobinson10• LinkedIn: https://www.linkedin.com/torierobinson• Facebook:https://www.facebook.com/TorieRobinsonSpeaker **CHECK OUT TORIE'S YOUTUBE & BLOG**• YouTube: https://www.youtube.com/c/TorieRobinson• Blog: https://www.torierobinson.com/blog**HIRE TORIE AS A SPEAKER ON EPILEPSY, MENTAL HEALTH, DISABILITY, & DIVERSITY**https://www.torierobinson.com/contact

Meet Caroline Scott, a Clinical Scientist and the Video Telemetry Service Lead at Birmingham Children's hospital. We shall be hearing about how she helps prepare children affected by refractory epilepsy for surgery and the massive positive differences that her care and both regular and intracranial EEGs offer.**CONNECT WITH CAROLINE**• https://bwc.nhs.uk/caroline-scott **READ ABOUT CAROLINE'S WORK**Birmingham Children's Hospital: https://partnersinpaediatrics.org/wp-content/uploads/2020/10/Welcome-to-CESS.pdf **CHECK OUT THE YOUTUBE VIDEO WITH CAROLINE**• YouTube: https://www.youtube.com/c/TorieRobinson/videos **CONNECT WITH TORIE**• Website: https://www.torierobinson.com• Twitter: https://twitter.com/torierobinson10• LinkedIn: https://www.linkedin.com/torierobinson• Facebook:https://www.facebook.com/TorieRobinsonSpeaker **CHECK OUT TORIE'S YOUTUBE & BLOG**• YouTube: https://www.youtube.com/c/TorieRobinson• Blog: https://www.torierobinson.com/blog**HIRE TORIE AS A SPEAKER ON EPILEPSY, MENTAL HEALTH, DISABILITY, & DIVERSITY**https://www.torierobinson.com/contact

  This Beat episode, hosted by Brian Mitzman MD, general thoracic surgeon with the University of Utah in Salt Lake City, focuses two recent publications and also a featured video on CTSNet. First, Dr Mitzman discusses a recent JTCVS expert opinion from Dr Craig Baker of USC discussing traditional and integrated models for cardiothoracic surgery training. He then dives into a recent Annals publication from the team at University Hospitals Cleveland Medical Center which analyzes the STS General Thoracic Database and evaluates postoperative day 1 discharge after lobectomy. Lastly, Dr Mitzman reviews a CTSNet featured video from Drs Watkins and Servais in Boston, where they run through tips and tricks for all five robotic lobectomies. For more information on this episode's topics, links are provided: Baker CJ. What is the optimal cardiothoracic surgery residency model? JTCVS Open. 2021; In Press. doi:10.1016/j.xjon.2021.01.012 Towe CW, Thibault DP, Worrell SG, et al. Factors associated with successful postoperative day one discharge following anatomic lung resection. Ann Thorac Surg. 2021; In Press. doi:10.1016/j.athoracsur.2020.07.059 Zhao K, Zhang J, Li S. Discharge on POD1 after anatomic lung resection to be treated with caution. Ann Thorac Surg. 2021; In Press. doi:10.1016/j.athoracsur.2020.12.094 Towe CW, Worrell SG, Finley DJ, et al. One day is here to stay. Ann Thorac Surg. 2021;In Press. doi:10.1016/j.athoracsur.2021.03.020 Linden PA, Perry Y, Worrell SG et al. Postoperative day 1 discharge after anatomic lung resection: A Society of Thoracic Surgeons database analysis. J Thorac Cardiovasc Surg. 2020;159:667-678. doi:10.1016/jtcvs.2019.08.038 Watkins A, Servais E. Robotic Lobectomy: Review of Anatomy and Technique for RUL, RML, RLL, LUL, and LLL.  

This Beat episode, featuring Brian Mitzman, general thoracic surgeon with the University of Utah in Salt Lake City, discusses recent highlights submitted to CTSNet along with a look at this weekend's Society of Thoracic Surgeons 57th Annual Meeting. For more information on this episode's topics, links are provided:Society of Thoracic Surgeons 57th Annual MeetingFontaine J-P, Parvathaneni A. Moffitt Technique. January 2021. doi:10.25373/ctsnet.13549418. Ceylan KC, Batihan G, Yazgan S, et al. Pleural complications in patients with coronavirus disease 2019 (COVID-19): How to safely apply and follow-up with a chest tube during the pandemic. Eur J Cardiothoracic Surg. 2020;58:1216-1221.

Joel Dunning interviews Raja Flores of the Mount Sinai School of Medicine about mesothelioma prevention and the persisting risk from asbestos exposure, as well as surgical methods to pursue for disease management.

Thoracic - Sleeve Lobectomy (Phil Moonsamy & Doug Mathisen) by TSRA

SCORE Modules Covered: Diseases/Conditions: Primary Hepatic Neoplasms - Benign and Malignant (Core, Malignant Only, See Also: 4.2 Benign Hepatic Neoplasms)

In this episode we address seizures and epilepsy including risk factors, diagnosis, numerous treatment options and important safety information. Dr Kate Hocquard joins the podcast to discuss misconceptions and important points she stresses with patients.Anti-Seizure MedicationsVagus Nerve Stimulator InfoKetogenic and Other Diet Treatments in EpilepsyCannabidiol (CBD) use in EpilepsySeizures and Driving Laws by StateIntro/Outro Music: Pinecrest by The Loyalist (Used with permission of the artist)Speaker(s) are employees of Mayo Clinic. The views/opinions expressed in the podcast are solely those of the speakers and do not represent those of Mayo Clinic or its subsidiaries.The Neuro Knowledge Podcast on Facebook!

An interactive discussion about malignant and benign pediatric thyroid disorders between Todd Ponsky, MD and Diana Diesen, MD. Dr. Diesen is assistant professor of surgery and pediatric surgery fellowship program director at the University of Texas Southwestern Medical Center and is a member of the Children's Health Pediatric Thyroid Center at the Children's Medical Center of Dallas. Contents 00:00 Introduction 02:31 Asymptomatic thyroid nodule 03:00 History 04:08 Risks factors for thyroid nodules and cancers 04:25 Family history 04:56 Physical exam 05:24 Physical exam pearls 06:03 Concerning physical exam findings 06:56 Laboratory evaluation 07:42 Thyroid scintigraphy 08:08 Hot thyroid nodules 09:13 Nodule with normal TSH 09:26 Thyroid ultrasound 10:15 Thyroid cysts 10:52 Lesion size and FNA biopsy 11:53 Anesthesia for FNA 12:30 Lymph node evaluation 13:12 Suspicious lymph node features 13:40 Papillary thyroid cancer 14:34 Lobectomy vs thyroidectomy 16:05 Thyroidecomy technique 17:07 Use of nerve monitor 17:40 Lymph node dissection 18:59 Post-operative management 20:37 Follow up 21:43 Radioactive iodine ablation 22:38 Thyroid hormone replacement therapy 22:54 Follicular cells on FNA 24:59 Frozen section for follicular lesions 25:55 Follicular carcinoma 26:36 Follicular adenoma 27:14 Pharmacologic TSH suppression 28:12 Benign FNA 29:45 Inadequate FNA specimen 30:32 Medullary carcinoma 33:22 Multiple endocrine neoplasia 37:26 Management of pheochromocytoma and hyperparathyroidism in MEN 2B 38:27 Central lymph node dissection in medullary thyroid cancer 39:42 Post-op medullary thyroid care 41:08 Recurrent/persistent medullary thyroid cancer 41:38 Systemic chemotherapy for MTC 42:03 Grave’s disease 42:57 Painful thyroid Intro track is adapted from "I dunno" by grapes, featuring J Lang, Morusque. Artist URL: ccmixter.org/files/grapes/16626 License: http://creativecommons.org/licenses/by/3.0/

An interactive discussion about pediatric lung lesions between Todd Ponsky, MD and Steve Rothenberg, MD. Dr. Rothenberg is Chief of Pediatric Surgery and the Chairman of the Department of Pediatrics at the Rocky Mountain Hospital for Children in Denver, CO. He is also faculty at Columbia University, College of Physicians and Surgeons in the Division of Pediatric Surgery as a Senior Consultant in Pediatric Minimal Access Surgery. Table of Contents 00:00 Introduction 02:46 Prenatal evaluation 04:11 Role of fetal MRI 04:30 Fetal imaging features 05:11 Choice of delivery location 06:01 Role of fetal intervention 07:09 Administration of corticosteroids 07:49 Cyst volume ratio 08:32 Spectrum of CPAM 11:16 Routine neonatal care 13:45 Role of neonatal MRI 15:15 Institutional variations in management 17:41 Decision to operate 20:10 Too small for thoracoscopic surgery? 21:59 Preoperative preparation 23:31 Anesthetic considerations 25:15 Avoidance of over-ventilation 26:36 Avoidance of high peak ventilator pressures 28:28 Patient positioning 30:02 Port placement 32:56 Instrument selection 35:17 Technique for vessel sealing 35:51 Vascular control 37:12 Vessel sealing devices 41:28 Left lower lobe technique 42:01 LLL-Take down inferior pulmonary ligament 42:31 LLL-Exposure of inferior pulmonary vein 42:44 LLL-Major fissure 43:46 LLL-Exposure of pulmonary artery 44:53 LLL-Dissection of superior segmental branch 45:11 LLL-Dissection of trunk to basal segments 45:33 LLL-Division of trunk 47:26 LLL-Division of the bronchus 49:33 LLL-Dissection of the pulmonary vein 50:33 Key point-Do not divide the trunk near the pericardium 51:02 Right lower lobe technique 51:46 Left upper lobe technique 52:17 LUL-Retraction 52:48 LUL-Identification of the pulmonary trunk 53:23 LUL- Exposure of the superior pulmonary vein 53:59 LUL- Isolation of venous supply to the lingula 54:25 LUL-Attention to the fissure 54:33 LUL-Lingular artery 54:54 LUL-Bronchus 55:12 LUL-Overview 55:40 Right middle lobe technique 56:43 RML-Pulmonary artery 57:05 Lobectomy technical pearls 57:38 Popping of lung cysts 58:33 Extralobar sequestration technique 59:48 Never use vessel sealer and clips on the same vessel 01:01:01 Alternative to resection of extralobar pulmonary sequestration 01:02:33 Role of segmental resection 01:04:41 Lobectomy post-operative course 01:05:50 Conclusion Intro track is adapted from "I dunno" by grapes, featuring J Lang, Morusque. Artist URL: ccmixter.org/files/grapes/16626 License: creativecommons.org/licenses/by/3.0/

There are multiple different types of lung cancer surgery. Dr. Eric Vallières, thoracic surgeon, reviews the different forms of lung surgery, include wedge resection, segmentectomy, lobectomy, and pneumonectomy.

There are multiple different types of lung cancer surgery. Dr. Eric Vallières, thoracic surgeon, reviews the different forms of lung surgery, include wedge resection, segmentectomy, lobectomy, and pneumonectomy.

There are multiple different types of lung cancer surgery. Dr. Eric Vallières, thoracic surgeon, reviews the different forms of lung surgery, include wedge resection, segmentectomy, lobectomy, and pneumonectomy.

Subroto Paul, MD, FCCP, and Malcolm M. DeCamp, MD, FCCP, take time to discuss the article by Dr. Paul and colleagues in the December 2014 issue of CHEST with Podcast Editor D. Kyle Hogarth, MD, FCCP. Their study evaluated the effectiveness of robotic-assisted vs thoracoscopic lobectomy. Thus far, in the early days of its use, they found that robotic-assisted lobectomy is associated with more injury and bleeding at a higher cost. The participants discussed potential future directions for robotics in this area.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video-assisted thoracic surgery to robotic surgery to sub-lobar resections and other developments offering new promising alternatives.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video-assisted thoracic surgery to robotic surgery to sub-lobar resections and other developments offering new promising alternatives.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video-assisted thoracic surgery to robotic surgery to sub-lobar resections and other developments offering new promising alternatives.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video-assisted thoracic surgery to robotic surgery to sub-lobar resections and other developments offering new promising alternatives.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video-assisted thoracic surgery to robotic surgery to sub-lobar resections and other developments offering new promising alternatives.

Dr. David Harpole of Duke University reviews advances in lung cancer surgery, covering techniques ranging from video-assisted thoracic surgery to robotic surgery to sub-lobar resections and other developments offering new promising alternatives.

Jennifer Quint, Thorax’s Journal Club editor, talks to Subroto Paul, Division of Thorasic Surgery at New York Presbrytarian Hospital System, about his study comparing short-term postoperative outcomes following open and thoracoscopic lobectomy.See also:http://www.ncbi.nlm.nih.gov/pubmed/22826474http://thorax.bmj.com/content/early/2012/08/23/thoraxjnl-2012-202521.full

Thoracic & Lung Cancers

Case discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.

Case discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.

Lap L hepatic lobectomy

Laparoscopic Left Hepatic Lobectomy

More than 200,000 people in the U.S. will be diagnosed with lung cancer in 2022, according to the National Cancer Institute. A new lung cancer diagnosis can be scary and confusing, but having a support system can help."Probably the best advice I give patients with lung cancer is to build your village of support around you," says Dr. Shanda Blackmon, a Mayo Clinic thoracic surgeon. "Always see if you can have somebody come with you for your appointment, just to help you emotionally deal with things, to help you record what's being said, to help you collect that information, and then to also advocate for you."If the cancer is confined to the lungs, surgery may be an option for treatment. Surgery is performed to remove the lung cancer and a margin of healthy tissue around the cancer site. Procedures to remove lung cancer include: Wedge resection to remove a small section of lung that contains the tumor along with a margin of healthy tissue. Segmental resection to remove a larger portion of lung, but not an entire lobe. Lobectomy to remove the entire lobe of one lung. Pneumonectomy to remove an entire lung. The surgeon also may remove lymph nodes from a patient's chest to check them for signs of cancer. The type of operation used for lung cancer treatment depends on the size and location of the cancer as well as how well a person's lungs are functioning. Dr. Blackmon recommends that patients explore all their surgical options."When you look at actual surgical options, you have minimally invasive surgery, or open surgery," explains Dr. Blackmon. "And the minimally invasive surgery has a lot of different options as well. Not every lung cancer surgery can be done minimally invasively. But if it can, certainly, the patient benefits."Another important consideration is having your lung cancer surgery performed at a center that does a high volume of cases and is familiar with the type of procedure needed."When you go to have your car worked on — you go to the dealership that deals with your car specifically and someone who does it every day — they're going to be doing a better job than going to someone who's never even seen that type, make or model of car," says Dr. Blackmon. "I think we do that in life all the time. And it makes sense to do it in medicine, and in surgery especially." After surgery for lung cancer, patients are often worried about short-term side effects, like shortness of breath and pain, as well as long-term worries about cancer recurrence. Both should be addressed as part of a cancer survivorship plan."Survivorship is part surveillance and part symptom management," says Dr. Blackmon. "The survivorship program here at Mayo Clinic really focuses on treating the whole patient. We have things like massage therapy. We have acupuncture. We have meditation. We have all kinds of resources that help patients to get their life back, get back in shape, and get all the parts of their body whole again as they start to heal from this really big surgery. But one thing that is so important is to continue to go back for that survivorship care with continued symptom monitoring and continued surveillance. That five-year period after the lung cancer surgery is so critically important."On this Mayo Clinic Q&A podcast, Dr. Blackmon discusses what people can expect after surgery for lung cancer, and how to achieve the best quality of life. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy